Verantos

As the year draws to a close, we at Verantos hope that you find health, happiness, and peace throughout 2025 and beyond.

A few weeks ago, some of our remote West Coast team members, took some time off from setting the quality standard for real-world evidence for a little team-building. As a remote-only company, we prioritize building and maintaining our connections, and our success is seen in our results.

We're proud to announce that Verantos' strong growth has been recognized with a listing on the Deloitte Technology Fast 500. This is the second year in a row that Verantos has been listed, and the second year in a row that Verantos was the only RWE company on the Fast 500. This ranking is a testament not only to acceptance of Verantos' mission in life sciences, but also the hard work and determination of the Verantos team.

We made the Inc 5000 list for the third year in a row and are the only real-world evidence company on the 2024 list! Congratulations to the Verantos team who have really advanced the mission of high-validity RWE.

PALO ALTO, Calif., Aug. 1, 2024 /PRNewswire/ -- Verantos, the global leader in high-validity real-world evidence at scale, today announced that Dr. Adam Cheifetz, M.D. of Beth Israel Deaconess Medical Center, and Gil Melmed, M.D. of Cedars-Sinai Medicine, have joined its advisory panel for inflammatory bowel disease (IBD). As senior faculty and experts, they will provide expert input on observational research powered by Verantos' Inflammatory Bowel Disease Pragmatic Registry.

There is a clear emphasis on validation throughout this final guidance document. We look forward to sharing our thoughts with you over the coming weeks.

We’re hiring at Verantos! Actively looking for MLOps Engineer and Data QA candidates for our Pune location. Quick Links: 📌 View Job Posting (https://lnkd.in/gnHTxtWV) 📘 Insightful Article by our CEO, Dan Riskin (https://lnkd.in/dfSyVJaQ) 🏆 Verantos on the 2023 Inc5000 List (https://lnkd.in/duK2_btb) Apply Now! Click on the job posting link above, and let’s start a conversation about the potential of working together. Feel free to tag someone who could be our next tech superstar! #Hiring #healthcare #TechJobs #MLOps #DataQA #JoinOurTeam #worklifebalance #respectatworkplace #jobs

PALO ALTO, Calif. , July 10, 2024 /PRNewswire/ -- Verantos, the global leader in high-validity real-world evidence at scale, today announced the launch of its Alzheimer's Disease Pragmatic Registry, which provides rich and reliable data on patients with Alzheimer's disease and related conditions to life sciences organizations.

Drop by our poster session or visit our booth at #ISPORAnnual next week. We're near the entrance and difficult to miss. We'll be happy to discuss how accuracy, completeness, and traceability of your RWD affect the measurement of health outcomes and resource utilization. And not just in migraine.

PALO ALTO, Calif., April 30, 2024 /PRNewswire/ -- Verantos, the global leader in high-validity real-world evidence at scale, today announced the launch of its Inflammatory Bowel Disease Pragmatic Registry, which provides rich and reliable data on ulcerative colitis and Crohn's disease patients, including specific subgroups to life sciences organizations. A pragmatic registry is a condition-specific, high-quality data set generated using artificial intelligence on routinely collected real-world data. By combining unstructured and structured data from electronic health records with linkage to claims and mortality data, Inflammatory Bowel Disease Pragmatic Registry offers an unparalleled view into disease severity, treatments, symptom control, resource utilization, and clinical outcomes variables.